EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

The extracellular CIRP as a predictive marker for the endothelial dysfunction in chronic obstructive pulmonary disease combined with pulmonary hypertension

Yun Yao, Haibo Jiang, Dalin Xu, Bing Zhang, Feng Yao, Wei Guo

BMC Pulmonary Medicine · 2024

DOI: 10.1186/s12890-024-03416-9 ↗

Kurz gefasst

Fachartikel in der Zeitschrift BMC Pulmonary Medicine, 2024. Verfasst von Yun Yao und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Respiratory and Critical Care Medicine, Anhui Provincial Lujiang County People's Hospital, Hefei, Anhui, P.R. China. Hauptthemen laut MEDLINE: Pulmonary Disease, Chronic Obstructive, Hypertension, Pulmonary, Biomarkers, Endothelium, Vascular. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: the National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Pulmonary hypertension (PH) is a serious complication of chronic obstructive pulmonary disease (COPD), distinguished by pulmonary endothelial dysfunction. The extracellular cold-inducible RNA-binding protein (eCIRP) is a damage-associated molecular pattern (DAMP) that triggers inflammation and causes vascular endothelial dysfunction in COPD-PH. METHODS: The expression levels of CIRP were compared in peripheral lung tissues among 40 individuals. Moreover, A prospective analysis was conducted on serum levels of eCIRP, interleukin (IL) 1β, IL-33, endothelin-1 (ET-1), and nitric oxide (NO) in 150 COPD patients and 50 healthy control individuals at Jiangsu Taizhou Peoples Hospital. The study aimed to compare these serum levels and correlations among COPD-PH group, COPD non-PH group and the normal group. RESULTS: We found higher CIRP levels in COPD-PH compared to COPD non-PH and the normal in lung tissue samples. A prospective analysis showed higher serum levels of eCIRP, IL-1β, IL-33, and ET 1 in COPD-PH, while a noticeable reduction in NO levels. There exists a correlation between the severity of COPD-PH and elevated levels of eCIRP, proinflammatory cytokines like IL-1β and IL-33, along with indicators of endothelial dysfunction like endothelin-1 ET-1 and NO. Moreover, the serum eCIRP level demonstrated a notable positive correlation with the levels of IL-1β, IL-33, PCT, and ET-1, while displaying a negative correlation with NO and Peripheral Oxygen Saturation (SpO2). Moreover, the serum eCIRP level demonstrated a notable positive correlation with the levels of IL-1β, IL-33, PCT, and ET-1, while displaying a negative correlation with NO and SpO2. Moreover, an assessment of independent risk factors for COPD-PH with ROC curve analysis, gauged the predictive value of serum eCIRP, IL-1β, IL-33, ET-1, and NO levels in diagnosing COPD-PH. Elevated eCIRP, IL-33, and ET-1 levels significantly correlated with COPD-PH, highlighting eCIRP's strong predictive value for this condition. CONCLUSION: eCIRP levels could serve as a valuable biomarker for predicting endothelial dysfunction in COPD-PH.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pulmonary Disease, Chronic ObstructiveHypertension, PulmonaryBiomarkersEndothelium, VascularHumansMaleFemaleMiddle AgedAgedProspective StudiesCase-Control StudiesEndothelin-1LungNitric OxideInterleukin-1betaInterleukin-33

Stichwörter der Autor:innen

COPDEndothelial dysfunctionInflammationPHeCIRP

Substanzen

BiomarkersEndothelin-1Nitric OxideInterleukin-1betaInterleukin-33

Autor:innen und Institutionen

  • Department of Respiratory and Critical Care Medicine, Anhui Provincial Lujiang County People's Hospital, Hefei, Anhui, P.R. China.
  • Department of Internal Medicine, Taizhou People's Hospital, Taizhou, Jiangsu, P.R. China.
  • Department of Clinical Pharmacology, The Second Affiliated Hospital of Anhui Medical University, Hefei, Anhui, P.R. China. yf301732@163.com.
  • Department of Respiratory and Critical Care Medicine, Anhui Provincial Lujiang County People's Hospital, Hefei, Anhui, P.R. China. yaoyunya2021@163.com.

Förderung

  • the National Natural Science Foundation of China

Zitieren

APA

Yao, Y., Jiang, H., Xu, D., Zhang, B., Yao, F., & Guo, W. (2024). The extracellular CIRP as a predictive marker for the endothelial dysfunction in chronic obstructive pulmonary disease combined with pulmonary hypertension. BMC Pulmonary Medicine. https://doi.org/10.1186/s12890-024-03416-9

Vancouver

Yao Y, Jiang H, Xu D, Zhang B, Yao F, Guo W. The extracellular CIRP as a predictive marker for the endothelial dysfunction in chronic obstructive pulmonary disease combined with pulmonary hypertension. BMC Pulmonary Medicine. 2024. doi:10.1186/s12890-024-03416-9

BibTeX
@article{Yao2024,
  author = {Yao, Yun and Jiang, Haibo and Xu, Dalin and Zhang, Bing and Yao, Feng and Guo, Wei},
  title = {The extracellular CIRP as a predictive marker for the endothelial dysfunction in chronic obstructive pulmonary disease combined with pulmonary hypertension},
  journal = {BMC Pulmonary Medicine},
  year = {2024},
  doi = {10.1186/s12890-024-03416-9}
}
Kostenlos starten →